Medical Advocates
HIV Drug Monitoring
  ARV Drug Resistance Testing
Guidelines

General
United States
 Resource-Limited Countries





 
ARV Drug Resistance Monitoring Main Page Main New//Newsworthy Home Page      
Last Update:  May 24, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Challenges
       
     Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT PDF ARTICLE
Establishing valid AIDS monitoring and research in countries with generalized epidemics.
Brody S, Potterat JJ.  
Int J STD AIDS. 2004 Jan;15(1):1-6
 Paper
United States
       

     Internet Documents

 
FULL TEXT PDF DOCUMENT
 Guidance for Industry on the Role of HIV Resistance Testing in Antiretroviral Drug Development. 
USFDA
October 2007
 Guidelines
 
FULL-TEXT DOCUMENT
 Draft: Guidance for Industry- Role of HIV Drug Resistance Testing in Antiretroviral Drug
Development
 US FDA 
November 26, 2004
 Guidelines

FULL-TEXT PDF ARTICLE
Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency
Virus Type 1: 2003 Recommendations of an International AIDS Society–USA Panel
 Hirsch MS ,Brun-Vézinet F, Clotet B, et al.
Guidelines     

  
Resource-Limited Countries
       
     Internet Documents
 
 
FULL-TEXT DOCUMENT
 Scaling Up Antiretroviral Therapy in Resource-Limited Settings:
Treatment Guidelines for a Public Health Approach--2003 Revision
[Available in English, French, Spanish, and Russian]
WHO, 2004
 Guidelines
 

ARV Drug Resistance Monitoring Main Page Main New//Newsworthy Home Page      

ARV Drug Resistance Testing Guidelines